Outcomes for Patients With Intermediate-, High-, and Very-High-Risk Prostate Cancer Treated With a Combination of External Beam Radiation Therapy and Brachytherapy

被引：0
|
作者：
Kiffel, J. [1 ]
Kiffel, E. R. [1 ]
Mandel, A. L. [1 ]
Stone, N. N. [1 ]
Stock, R. G. [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2015年 / 93卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2015.07.1056
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2503
引用
收藏
页码：E199 / E200
页数：2
相关论文
共 50 条
  • [1] Lack of Benefit From the Addition of External Beam Radiation Therapy to Brachytherapy for Intermediate- and High-risk Prostate Cancer
    Yang, David D.
    Muralidhar, Vinayak
    Nguyen, Paul L.
    Buzurovic, Ivan
    Martin, Neil E.
    Mouw, Kent W.
    Devlin, Phillip M.
    Quoc-Dien Trinh
    Orio, Peter F., III
    King, Martin T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (04): : 904 - 911
  • [2] Health-Related Quality of Life and Efficacy Outcomes of Cs-131 Brachytherapy in Combination With External Beam Radiation Therapy in Patients With Intermediate- and High-Risk Prostate Cancer
    Harrell, L. M.
    Allbright, R. M.
    Zhang, X.
    Woods, W. C., III
    Mobit, P. N.
    Baird, M. C.
    Pound, C.
    Ma, J. K.
    Kanakamedala, M. R.
    Packianathan, S.
    Vijayakumar, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E231 - E232
  • [3] Outcomes and toxicities in patients with intermediate-risk prostate cancer treated with brachytherapy alone or brachytherapy and supplemental external beam radiation therapy
    Markovic, Emily Schlussel
    Buckstein, Michael
    Stone, Nelson N.
    Stock, Richard G.
    BJU INTERNATIONAL, 2018, 121 (05) : 774 - 780
  • [4] External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis
    Patel, Sagar A.
    Ma, Ting Martin
    Wong, Jessica K.
    Stish, Bradley J.
    Dess, Robert T.
    Pilar, Avinash
    Reddy, Chandana
    Wedde, Trude B.
    Lilleby, Wolfgang A.
    Fiano, Ryan
    Merrick, Gregory S.
    Stock, Richard G.
    Demanes, D. Jeffrey
    Moran, Brian J.
    Tran, Phuoc T.
    Krauss, Daniel J.
    Abu-Isa, Eyad I.
    Pisansky, Thomas M.
    Choo, C. Richard
    Song, Daniel Y.
    Greco, Stephen
    Deville, Curtiland
    DeWeese, Theodore L.
    Tilki, Derya
    Ciezki, Jay P.
    Karnes, R. Jeffrey
    Nickols, Nicholas G.
    Rettig, Matthew B.
    Feng, Felix Y.
    Berlin, Alejandro
    Tward, Jonathan D.
    Davis, Brian J.
    Reiter, Robert E.
    Boutros, Paul C.
    Romero, Tahmineh
    Horwitz, Eric M.
    Tendulkar, Rahul D.
    Steinberg, Michael L.
    Spratt, Daniel E.
    Xiang, Michael
    Kishan, Amar U.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 115 (03): : 645 - 653
  • [5] Intermediate- to high-risk prostate cancer patient treated with radiation therapy
    Raben, David
    Lucia, Scott
    Glode, Michael
    Crawford, E. David
    Kavanagh, Brian
    Raben, Adam
    Ayres, Jennifer
    ONCOLOGY-NEW YORK, 2004, 18 (09): : 1105 - 1110
  • [6] Sabatolimab in Combination with Hypomethylating Agents (HMAs) Was Safe in Patients (Pts) with Intermediate-, High-, or Very-High-Risk Myelodysplastic Syndrome (MDS)
    Garcia-Manero, Guillermo
    Lyons, Roger M.
    Nandal, Savita
    Ashraf, Mushtaq
    Thellaboina, Ramarao
    Ruckel-Kumar, Julie
    Menssen, Hans D.
    Zeidan, Amer M.
    BLOOD, 2023, 142
  • [7] A comparison of outcomes for patients with intermediate and high risk prostate cancer treated with low dose rate and high dose rate brachytherapy in combination with external beam radiotherapy
    Slevin, Finbar
    Rodda, Sree Lakshmi
    Bownes, Peter
    Murray, Louise
    Bottomley, David
    Wilkinson, Clare
    Adiotomre, Ese
    Al-Qaisieh, Bashar
    Dugdale, Emma
    Hulson, Oliver
    Mason, Joshua
    Smith, Jonathan
    Henry, Ann M.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2020, 20 : 1 - 8
  • [8] Brachytherapy versus external beam radiation therapy in high intermediate risk endometrial cancer patients
    Delic, L.
    Cass, I.
    Li, A.
    Leuchter, R.
    Karlan, B. Y.
    Walsh, C.
    GYNECOLOGIC ONCOLOGY, 2008, 111 (02) : 383 - 384
  • [9] Escalating the dose of high-dose-rate brachytherapy combined with external beam radiotherapy improves the disease control rate in patients with high- or very-high-risk prostate cancer
    Inagaki, Takaya
    Noda, Yasutaka
    Iwahashi, Yuya
    Naka, Takahiro
    Kojima, Maria
    Inagaki, Riki
    Shimono, Ryuki
    Awaya, Azusa
    Kohjimoto, Yasuo
    Hara, Isao
    Sonomura, Tetsuo
    BRACHYTHERAPY, 2025, 24 (02) : 223 - 230
  • [10] Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy
    Stock, Richard G.
    Cesaretti, Jamie A.
    Hall, Simon J.
    Stone, Nelson N.
    BJU INTERNATIONAL, 2009, 104 (11) : 1631 - 1636
12345